Recent clinical data surrounding Retatrutide , specifically the high-dose formulation branded as ZPHC, reveal a significant benefit on body mass reduction and associated health conditions . Scientists believe that this dual compound, targeting both GLP-1 and GIP pathways , has the potential to represent a major improvement in the approach of overwe